The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma

Published:2016-09-13 Issue:6 Volume:175 Page:1210-1220
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

McConnell A.T.¹,Ellis R.¹²,Pathy B.¹,Plummer R.³,Lovat P.E.¹,O'Boyle G.¹⁴

Affiliation:

1. Dermatological Sciences; Institute of Cellular Medicine; Newcastle University; Newcastle upon Tyne U.K.

2. James Cook University Hospital; Middlesbrough U.K.

3. Northern Institute for Cancer Research; Newcastle University; Newcastle upon Tyne U.K.

4. Faculty of Applied Sciences; University of Sunderland; Sunderland U.K.

Funder

Medical Research Council

Cancer Research U.K

British Skin Foundation

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14720/fullpdf

Reference31 articles.

1. Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy;Eroglu;Ther Adv Med Oncol,2016

2. PD-1 blockade induces responses by inhibiting adaptive immune resistance;Tumeh;Nature,2014

3. Chemokines in health and disease;Raman;Exp Cell Res,2011

4. Cancer and the chemokine network;Balkwill;Nat Rev Cancer,2004

5. Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070;O'Boyle;Br J Cancer,2013

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is it possible to treat melanoma by intercepting the CXCR4/CXCL12 pathway?;Cytokine;2024-07

2. Diagnostic value of [68Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study;Nuclear Medicine Communications;2024-01-12

3. Cross‑talk between lymphangiogenesis and malignant melanoma cells: New opinions on tumour drainage and immunization (Review);Oncology Letters;2024-01-05

4. The role of PKC and PKD in CXCL12 and CXCL13 directed malignant melanoma and acute monocytic leukemic cancer cell migration;Cellular Signalling;2024-01

5. EPI-X4, a CXCR4 antagonist inhibits tumor growth in pancreatic cancer and lymphoma models;Peptides;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3